We developed a rule-based data filter for the automatic interpretation of data transmitted from implantable cardioverter defibrillators (ICDs). The feasibility and user acceptability of the data filter were tested in a multicentre study. Fifteen European centres analysed 10 cases each. The cases represented ICD follow-up findings, e.g. new tachycardia, battery depletion or sensing defects. The mean follow-up period was 68 days (SD 35). A questionnaire was used to collect information regarding the functionality and general concept of automatic data interpretation. A score of five or above (range 1-9) was classified as acceptable. According to the questionnaires, there was a high degree of satisfaction with the general concept of automatic data interpretation (mean 6.7, SD 1.2) and with user guidance (mean 7.1, SD 0.8). Safety (mean 7.0, SD 1.4) and accuracy (mean 6.7, SD 1.4) of the evaluation of device-related and clinical problems were regarded as high. Support in daily routine was considered to be high (mean 7.3, SD 1.1) as the system was easy to understand (mean 7.5, SD 0.9). The results indicated a high user acceptance with easy system handling.

Download full-text PDF

Source
http://dx.doi.org/10.1258/135763306776084347DOI Listing

Publication Analysis

Top Keywords

data filter
12
rule-based data
8
cardioverter defibrillators
8
general concept
8
concept automatic
8
automatic data
8
data interpretation
8
data
6
multicentre evaluation
4
evaluation rule-based
4

Similar Publications

Liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS) is commonly used for identification of compounds in complex samples due to the high chromatographic and mass spectral resolution provided. In subsequent data processing workflows, it is imperative to preserve this resolution to fully exploit the data. "Region of interest" (ROI) algorithms were introduced as a better alternative to equidistant binning for compressing HRMS data because they better preserve the mass spectral resolution.

View Article and Find Full Text PDF

Background: Type 2 diabetes (T2D) is a prevalent health condition associated with cognitive impairment and dementia. T2D induces adverse effects not only on the pancreas but also on the liver, kidneys, muscles, fat cells, and, notably, the brain. Both T2D and Alzheimer's disease (AD) exhibit associations with neurodegeneration, yet the extent of their shared patterns of brain atrophy remains poorly understood, potentially indicating common pathways.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

NeuroXT, Seoul, Korea, Republic of (South).

Background: Glymphatic system dysfunction as characterized by increased MRI-visible Perivascular Spaces (PVS) is speculated to play a role in the acceleration of amyloid accumulation in Alzheimer's Disease (AD). However, while PVS is also prevalent amongst Vascular Dementia (VD), the pathological distinctions between regional PVS in AD- and VD-driven cohorts remain largely unknown. Through a mixed dementia cohort, we examined these pathology-driven localization patterns via automated PVS segmentations from T2-weighted MRI.

View Article and Find Full Text PDF

Background: The increasing prevalence of cognitive impairment and dementia threatens global health, necessitating the development of accessible tools for detection of cognitive impairment. This study explores using a transformer-based approach to detect cognitive impairment using acoustic markers of spontaneous speech.

Method: Recordings of unstructured interviews from baseline visits were obtained from participants of The 90+ Study, a longitudinal study of individuals older than 90 years.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, Scotland, UK.

Background: To date, all computerised perivascular spaces (PVS) quantification methods require case-wise, imaging modality, or study-specific parameter adjustments, and suffer from generalisability problems in clinical settings, and misdetection of other cerebral small vessel disease (CSVD) markers. We propose a deep learning-based PVS detection method to overcome these issues. We compare our proposal on magnetic resonance imaging data of CSVD participants against the performance of the Frangi filter.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!